2574.3000 -164.95 (-6.02%)
NSE Apr 07, 2025 15:31 PM
Volume: 147.9K
 

2574.30
-6.02%
Karvy
Revenue growth lower than estimates: Revenues for the quarter at Rs 8821 mn were below our estimates of Rs 9469mn on account of lower traction.
GlaxoSmithKline Phar.. has an average target of 2630.00 from 2 brokers.
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended